You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adenovirus

Showing 1 - 25 of 927
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

Adenovirus Infection in Children With Autoimmune Hepatitis

Not yet recruiting
  • Observational
  • Pcr
  • (no location specified)
Jan 20, 2023

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Primary Hepatocellular Carcinoma, Portal Vein Thrombosis Trial (Recombinant human adenovirus type 5 + TACE)

Not yet recruiting
  • Primary Hepatocellular Carcinoma
  • Portal Vein Thrombosis
  • Recombinant human adenovirus type 5 + TACE
  • (no location specified)
May 14, 2023

Cytomegalovirus, Adenovirus Trial in Memphis (VST infusion, CliniMACS)

Not yet recruiting
  • Cytomegalovirus
  • Adenovirus
  • VST infusion
  • CliniMACS
  • Memphis, Tennessee
    St . Jude Children's Research Hospital
Jan 9, 2023

Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)

Not yet recruiting
  • Malignant Melanoma
  • Liver Metastases
  • Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
  • (no location specified)
Dec 23, 2022

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

Adenovirus Infections in Allogenic Hematopoietic Cell Transplant

Completed
  • Adenovirus Infections, Human
    • (no location specified)
    Mar 10, 2022

    COVID-19 Trial in Singapore (Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation)

    Not yet recruiting
    • COVID-19
    • Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation
    • Singapore, Singapore
      National University Hospital
    Jan 29, 2023

    COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

    Active, not recruiting
    • COVID-19
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
    • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
    • Yancheng, Jiangsu, China
      Funing Center for Disease Control and Prevention
    Oct 28, 2022

    Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

    Recruiting
    • Adenovirus
    • Primary Immune Deficiency Disorder
    • cytotoxic t-lymphocytes
    • Los Angeles, California
    • +8 more
    Sep 27, 2022

    Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)

    Recruiting
    • Bladder Cancer
    • H101, Camrelizumab
    • Hangzhou, Zhejiang, China
      Hua Wang
    Oct 2, 2022

    Adenovirus Type-5 Vectored COVID-19 Vaccine Trial in Wuhan (Adenovirus Type-5 Vectored COVID-19 Vaccine)

    Completed
    • Adenovirus Type-5 Vectored COVID-19 Vaccine
    • Adenovirus Type-5 Vectored COVID-19 Vaccine
    • Wuhan, Hubei, China
      A rehabilitation centre in Wuhan
    Mar 28, 2022

    COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

    Recruiting
    • COVID-19
    • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
    • +2 more
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jun 1, 2023

    Ebola Virus Trial in Kampala (cAd3-EBO S vaccine)

    Completed
    Has Results
    • Ebola Virus
    • cAd3-EBO S vaccine
    • Kampala, Uganda
      Makerere University-Walter Reed Project
    Nov 10, 2022

    Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

    Recruiting
    • Head and Neck Cancer
    • +6 more
    • Recombinant L-IFN adenovirus injection
    • Shanghai, Shanghai, China
      Shanghai Fengxian District Central Hospital
    Jan 16, 2022

    Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Trial

    Recruiting
    • Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
    • Recombinant adenovirus type-5-vectored COVID-19 vaccine
    • Hangzhou, Zhejiang, China
      Xihu District Center for Disease Control and Prevention
    May 12, 2022

    Herpes Zoster Trial in Halifax (Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV), Zoster Vaccine Recombinant,

    Not yet recruiting
    • Herpes Zoster
    • Recombinant Zoster Vaccine (Adenovirus Vector) (ChAdOx1-VZV)
    • +5 more
    • Halifax, Canada
      Canadian Center for Vaccinology
    Aug 6, 2023

    Cholangiocarcinoma, Intrahepatic Trial in Beijing (Recombinant Human Adenovirus Type 5, HAIC of FOLFOX)

    Not yet recruiting
    • Cholangiocarcinoma, Intrahepatic
    • Recombinant Human Adenovirus Type 5
    • HAIC of FOLFOX
    • Beijing, Beijing, China
      Beijing Tsinghua Chang Gung Hospital
    Mar 16, 2022

    Advanced/Metastatic Solid Tumours Trial in Canada (MG1MA3, AdMA3)

    Active, not recruiting
    • Advanced/Metastatic Solid Tumours
    • MG1MA3
    • AdMA3
    • Vancouver, British Columbia, Canada
    • +3 more
    Jan 30, 2023

    Melanoma, Head and Neck Squamous Cell Carcinoma Trial in Helsinki (TILT-123, Avelumab)

    Recruiting
    • Melanoma
    • Head and Neck Squamous Cell Carcinoma
    • Helsinki, Finland
      Docrates Cancer Center
    Jul 12, 2022